@glyco @McDuff
Day 1 relisted on the ASX.
I share your concerns; revenue is low relative to market cap but it's still at an early stage.
MDR revenue is currently made up of:
-Pharmacies paying a monthly fee to offer MedAdvisor
-Drug makers paying MedAdvisor a fee to deliver messages to patients
-They can also advertise on the MedAdvisor platform (which I'm sure we will see more of in 2016 - drug makers, Medibank, Bupa, pharmacies, doctor clinics etc.)
It's still at an early stage- available at 25% of Australian pharmacies and used by only 100,000 Australians. Clear room for growth. 500,000 Australian and 50% of pharmacies the next target. Onwards and upwards I say!
MedAdvisor off and running, page-47
-
- There are more pages in this discussion • 83 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add MDR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
30.0¢ |
Change
0.010(3.45%) |
Mkt cap ! $215.0M | |||
| Open | High | Low | Value | Volume |
| 29.0¢ | 30.0¢ | 27.5¢ | $254.8K | 889.6K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 39326 | 30.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 30.5¢ | 2917 | 1 |
View Market Depth
| Last trade - 16.10pm 15/11/2024 (20 minute delay) ? |
| MDR (ASX) Chart |
